                         SEQUENCE LISTING

<110>  Administracin General de la Comunidad Autnoma de Euskadi / UNIVERSIDAD DEL PAS VASCO/EUSKAL HERRIKO UNIBERTSITATEA
 
<120>  FOXO INHIBITORS FOR USE IN THE TREATMENT OF DISEASES CAUSED BY ABNORMAL PROCESSING OF TDP-43 AND/OR FUS PROTEINS

<130>  906 299

<160>  6     

<170>  PatentIn version 3.5

<210>  1
<211>  63
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Artificial sequence

<400>  1

Lys Gly Asp Ser Asn Ser Ser Ala Gly Trp Lys Asn Ser Ile Arg His 
1               5                   10                  15      


Asn Leu Ser Leu His Ser Lys Phe Ile Arg Val Gln Asn Glu Gly Thr 
            20                  25                  30          


Gly Lys Ser Ser Trp Trp Met Leu Asn Pro Glu Gly Gly Lys Ser Gly 
        35                  40                  45              


Lys Ser Pro Arg Arg Arg Ala Ala Ser Met Asp Asn Asn Ser Lys 
    50                  55                  60              


<210>  2
<211>  61
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Artificial sequence

<400>  2

Lys Gly Asp Ser Asn Ser Ser Ala Gly Trp Lys Asn Ser Ile Arg His 
1               5                   10                  15      


Asn Leu Ser Leu His Asn Arg Phe Met Arg Val Gln Asn Glu Gly Thr 
            20                  25                  30          


Gly Lys Ser Ser Trp Trp Met Leu Asn Pro Glu Ala Lys Pro Gly Lys 
        35                  40                  45              


Ser Val Arg Arg Arg Ala Ala Ser Met Glu Thr Ser Arg 
    50                  55                  60      


<210>  3
<211>  63
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Artificial sequence

<400>  3

Lys Gly Asp Ser Asn Ser Ser Ala Gly Trp Lys Asn Ser Ile Arg His 
1               5                   10                  15      


Asn Leu Ser Leu His Ser Lys Phe Ile Arg Val Gln Asn Glu Gly Thr 
            20                  25                  30          


Gly Lys Ser Ser Trp Trp Met Leu Asn Pro Glu Gly Gly Lys Ser Gly 
        35                  40                  45              


Lys Ser Pro Arg Arg Arg Ala Ala Ser Met Asp Asn Asn Ser Lys 
    50                  55                  60              


<210>  4
<211>  63
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Artificial sequence

<400>  4

Lys Gly Asp Ser Asn Ser Ser Ala Gly Trp Lys Asn Ser Ile Arg His 
1               5                   10                  15      


Asn Leu Ser Leu His Ser Lys Phe Ile Arg Val Gln Asn Glu Gly Thr 
            20                  25                  30          


Gly Lys Ser Ser Trp Trp Met Leu Asn Pro Glu Gly Gly Lys Ser Gly 
        35                  40                  45              


Lys Ser Pro Arg Arg Arg Ala Ala Ser Met Asp Asn Asn Ser Lys 
    50                  55                  60              


<210>  5
<211>  63
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Artificial sequence

<400>  5

Lys Gly Asp Ser Asn Ser Ser Ala Gly Trp Lys Asn Ser Ile Arg His 
1               5                   10                  15      


Asn Leu Ser Leu His Ser Lys Phe Ile Arg Val Gln Asn Glu Gly Thr 
            20                  25                  30          


Gly Lys Ser Ser Trp Trp Met Leu Asn Pro Glu Gly Gly Lys Ser Gly 
        35                  40                  45              


Lys Ser Pro Arg Arg Arg Ala Ala Ser Met Asp Asn Asn Ser Lys 
    50                  55                  60              


<210>  6
<211>  63
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Artificial sequence

<400>  6

Lys Gly Asp Ser Asn Ser Ser Ala Gly Trp Lys Asn Ser Ile Arg His 
1               5                   10                  15      


Asn Leu Ser Leu His Ser Lys Phe Ile Arg Val Gln Asn Glu Gly Thr 
            20                  25                  30          


Gly Lys Ser Ser Trp Trp Met Leu Asn Pro Glu Gly Gly Lys Ser Gly 
        35                  40                  45              


Lys Ser Pro Arg Arg Arg Ala Ala Ser Met Asp Asn Asn Ser Lys 
    50                  55                  60              


